MEDS: יחס הלוואות לטווח ארוך להון trxadehealth.com
The asset value of TRxADE HEALTH, Inc. (MEDS) tracked on the GURU.Markets chart is 0.00, which correlates with the development of cloud B2B solutions and the implementation of AI in MedTech. Financial stability is based on support from online pharmacies and steady demand for medications. However, the business is currently undergoing a rigorous transformation due to displacement by major logistics players and a loss of position in digital distribution.
%20-%20%D7%99%D7%97%D7%A1%20%D7%97%D7%95%D7%91%20%D7%9C%D7%98%D7%95%D7%95%D7%97%20%D7%90%D7%A8%D7%95%D7%9A%20%D7%9C%D7%94%D7%95%D7%9F%20%D7%A2%D7%A6%D7%9E%D7%99&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_MEDS_-_TRxADE-HEALTH-Inc._-_Long-Term-Debt-to-Equity-Ratio "MEDS - מקדם חוב לטווח ארוך להון TRxADE HEALTH בטווח 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים מקיפים ואנליטיקה עבור TRxADE HEALTH, Inc. (MEDS)
To conduct high-quality stock selection, an investor must evaluate the stability of a company's financial leverage. This ratio compares liabilities with a maturity of over one year against the amount of equity. The asset-light model of TRxADE HEALTH (MEDS) featuring SaaS subscriptions minimizes the need for debt financing. This confirms the efficiency of a structure devoid of capital expenditures on logistics. An analysis of the long-term debt-to-equity ratio demonstrates high reliability and a conservative approach to debt.